Filing Details

Accession Number:
0001209191-18-061480
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-07 16:12:38
Reporting Period:
2018-12-07
Accepted Time:
2018-12-07 16:12:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1515673 Ultragenyx Pharmaceutical Inc. RARE Pharmaceutical Preparations (2834) 272546083
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1598426 William Aliski C/O Ultragenyx Pharmaceutical Inc.
60 Leveroni Court
Novato CA 94949
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-07 6,000 $49.69 90,350 No 4 S Indirect By trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 72,610 Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a trading plan adopted by the Reporting Person's trust pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse and nephew are trustees of the trust.